LRIG2 and neoplasm: Inactivation of PTEN plays an important role in human cSCC development (Darido et al., 2018; Hertzler‐Schaefer et al., 2014), consequently the loss of PTEN tumor‐suppressive function might be an important element of LRIG2‐mediated tumor progression during skin cancer.